|
DE2947526A1
(de)
|
1978-11-29 |
1980-06-12 |
Ono Pharmaceutical Co |
Prostacyclin-analoge
|
|
US4668814A
(en)
|
1984-03-08 |
1987-05-26 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
JPS61289034A
(ja)
|
1985-06-17 |
1986-12-19 |
Teijin Ltd |
イソカルバサイクリン類脂肪乳剤
|
|
US4837342A
(en)
|
1986-02-28 |
1989-06-06 |
Sagami Chemical Research Center |
Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient
|
|
GB8814438D0
(en)
|
1988-06-17 |
1988-07-20 |
Wellcome Found |
Compounds for use in medicine
|
|
GB9011588D0
(en)
|
1990-05-24 |
1990-07-11 |
Wellcome Found |
Prostaglandin analogues for use in medicine
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
CA2056039A1
(en)
|
1991-01-22 |
1992-07-23 |
Philip L. Fuchs |
Carbacyclin analogs
|
|
US5190972A
(en)
|
1992-01-27 |
1993-03-02 |
The University Of Melbourne |
Method of combatting cyclosporine organ toxicity with prostaglandin analogs
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
|
US6441245B1
(en)
|
1997-10-24 |
2002-08-27 |
United Therapeutics Corporation |
Process for stereoselective synthesis of prostacyclin derivatives
|
|
ES2214753T3
(es)
|
1997-11-14 |
2004-09-16 |
United Therapeutics Corporation |
Uso de 9-desoxi-2',9-alfa-metano-3-oxa-4,5,6-trinor-3,7-(1',3'-interfenilen)-13,14-dihidro-prostaglandina f1 para tratar la enfermedad vascular periferica.
|
|
AU1689599A
(en)
|
1997-12-26 |
1999-07-19 |
Toray Industries, Inc. |
Sustained release medicinal compositions
|
|
JP2002521423A
(ja)
|
1998-07-31 |
2002-07-16 |
コリア インスティチュート オブ サイエンス アンド テクノロージ |
遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子
|
|
US6265495B1
(en)
*
|
1998-09-22 |
2001-07-24 |
Nippon Shokubai Co., Ltd. |
Method for production of esterified product
|
|
US6521212B1
(en)
|
1999-03-18 |
2003-02-18 |
United Therapeutics Corporation |
Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
|
|
CN1354622A
(zh)
|
1999-03-31 |
2002-06-19 |
联合治疗公司 |
前列腺素类化合物、组合物和治疗外周血管疾病和肺动脉高压的方法
|
|
US6242482B1
(en)
|
2000-06-05 |
2001-06-05 |
United Therapeutics Corporation |
Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
|
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
|
US6991809B2
(en)
|
2001-06-23 |
2006-01-31 |
Lyotropic Therapeutics, Inc. |
Particles with improved solubilization capacity
|
|
US20030108512A1
(en)
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
|
US6803386B2
(en)
|
2002-01-16 |
2004-10-12 |
United Therapeutics Corporation |
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
|
|
US20040156816A1
(en)
|
2002-08-06 |
2004-08-12 |
David Anderson |
Lipid-drug complexes in reversed liquid and liquid crystalline phases
|
|
MXPA05012467A
(es)
|
2003-05-19 |
2006-02-22 |
Baxter Int |
Particulas solidas que comprenden un anticonvulsivo o un inmunosupresor revestido con uno o mas modificadores de superficie.
|
|
ES2272914T3
(es)
|
2003-05-20 |
2007-05-01 |
Ethypharm |
Composicion farmaceutica oral de liberacion sostenida.
|
|
CN101780092B
(zh)
|
2003-05-22 |
2012-07-04 |
联合治疗公司 |
化合物和释放前列环素类似物的方法
|
|
JP5190200B2
(ja)
|
2003-12-16 |
2013-04-24 |
ユナイテッド セラピューティクス コーポレイション |
虚血性病変の治療および予防のためのトレプロスチニルの用途
|
|
KR20060123482A
(ko)
|
2003-12-16 |
2006-12-01 |
유나이티드 쎄러퓨틱스 코포레이션 |
신장 기능을 개선하기 위한 트레프로스티닐의 용도
|
|
DE602005020269D1
(de)
|
2004-04-12 |
2010-05-12 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
|
|
GB0416328D0
(en)
|
2004-07-21 |
2004-08-25 |
Univ Cardiff |
Use of dry powder compositions for pulmonary delivery
|
|
CN101090714A
(zh)
|
2004-07-26 |
2007-12-19 |
康泽里克斯公司 |
通过吸入伊洛前列素和微粒制剂治疗肺动脉高血压症
|
|
US7858650B2
(en)
|
2004-10-22 |
2010-12-28 |
Ono Pharmaceutical Co., Ltd. |
Medicinal composition for inhalation
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
WO2007134292A2
(en)
|
2006-05-15 |
2007-11-22 |
United Therapeutics Corporation |
Treprostinil administration using a metered dose inhaler
|
|
WO2008049000A2
(en)
|
2006-10-18 |
2008-04-24 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
WO2008098196A1
(en)
|
2007-02-09 |
2008-08-14 |
United Therapeutics Corporation |
Treprostinil treatment for interstitial lung disease and asthma
|
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
|
JP2010538092A
(ja)
|
2007-09-07 |
2010-12-09 |
ユナイテッド セラピューティクス コーポレーション |
グラム陰性菌に対して選択的殺菌活性を有するバッファー溶液およびそれを使用する方法
|
|
CA2710205C
(en)
|
2007-12-17 |
2016-04-26 |
United Therapeutics Corporation |
An improved process to prepare treprostinil, the active ingredient in remodulin
|
|
US8350079B2
(en)
|
2008-05-08 |
2013-01-08 |
United Therapeutics Corporation |
Treprostinil formulation
|
|
WO2009152160A1
(en)
|
2008-06-10 |
2009-12-17 |
Gilead Sciences, Inc. |
Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
|
|
US20110294815A1
(en)
|
2008-06-27 |
2011-12-01 |
Harbeson Scott L |
Prostacyclin analogs
|
|
WO2010039531A1
(en)
|
2008-09-23 |
2010-04-08 |
Resolvyx Pharmaceuticals, Inc. |
Therapeutic compounds
|
|
WO2010036798A1
(en)
|
2008-09-25 |
2010-04-01 |
Aradigm Corporation |
Deep lung pulmonary delivery of treprostinil
|
|
US20100216877A1
(en)
|
2009-02-20 |
2010-08-26 |
Micro Labs Limited |
Storage Stable Prostaglandin Product
|
|
EP2427054A4
(en)
|
2009-05-07 |
2014-01-15 |
United Therapeutics Corp |
SOLID COMPOSITIONS BASED ON PROSTACYCLINE ANALOGS
|
|
WO2011005505A2
(en)
|
2009-06-22 |
2011-01-13 |
Johnson Matthey Public Limited Company |
Method for the purification of prostaglandins
|
|
WO2011003058A1
(en)
|
2009-07-03 |
2011-01-06 |
Concert Pharmaceuticals, Inc. |
Prostacyclin derivatives
|
|
EP2461812B1
(en)
|
2009-08-07 |
2014-01-01 |
SciPharm SàRL |
Composition for the treatment of cystic fibrosis
|
|
PH12012500360A1
(en)
|
2009-08-21 |
2019-07-10 |
Targeted Delivery Tech Limited |
Vesicular formulations
|
|
CN101669904B
(zh)
|
2009-09-29 |
2011-06-22 |
北京中海康医药科技发展有限公司 |
一种依前列醇脂质纳米粒及制备方法
|
|
DK2525830T3
(en)
|
2010-01-22 |
2016-08-15 |
Ascendis Pharma As |
DIPEPTID-BASED PRODRUG LINKERS TO ALIFATIC AMINE-CONTAINING MEDICINES
|
|
WO2011089215A1
(en)
|
2010-01-22 |
2011-07-28 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aromatic amine-containing drugs
|
|
EP2547341B1
(en)
|
2010-03-15 |
2016-09-14 |
United Therapeutics Corporation |
Treatment for pulmonary hypertension
|
|
KR101868166B1
(ko)
|
2010-06-03 |
2018-06-15 |
유나이티드 세러퓨틱스 코오포레이션 |
트레프로스티닐의 제조
|
|
EP2582235A4
(en)
|
2010-06-15 |
2014-04-30 |
United Therapeutics Corp |
ORAL TREATMENT OF DIGITAL ISCHEMIC LESIONS
|
|
US20120010159A1
(en)
|
2010-07-09 |
2012-01-12 |
United Therapeutics Corporation |
Combination therapies with cox-2 inhibitors and treprostinil
|
|
CA2710726C
(en)
|
2010-07-22 |
2016-02-23 |
Alphora Research Inc. |
Synthesis of treprostinil and intermediates useful therein
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
JP5780775B2
(ja)
|
2011-02-18 |
2015-09-16 |
株式会社Ｌｔｔバイオファーマ |
プロスタグランジンｉ２誘導体を含有するナノ粒子
|
|
US20130345471A1
(en)
|
2011-03-02 |
2013-12-26 |
United Therapeutics Corporation |
Synthesis of intermediate for treprostinil production
|
|
JP5850915B2
(ja)
|
2011-03-14 |
2016-02-03 |
国立大学法人北海道大学 |
肺送達のためのベクター、導入剤及び使用
|
|
EP2741782B1
(en)
|
2011-08-12 |
2020-05-06 |
Ascendis Pharma A/S |
Protein carrier-linked prodrugs
|
|
BR112014003240A2
(pt)
|
2011-08-12 |
2017-03-01 |
Ascendis Pharma As |
composição de prostaciclina com liberação sustentada
|
|
AU2012296949B2
(en)
|
2011-08-12 |
2016-09-15 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
KR101997939B1
(ko)
|
2011-08-12 |
2019-07-08 |
아센디스 파마 에이에스 |
담체-연결된 트레프로스티닐 전구약물
|
|
AU2012296950B2
(en)
|
2011-08-12 |
2016-09-22 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
|
HK1198913A1
(en)
|
2011-08-12 |
2015-06-19 |
Ascendis Pharma A/S |
Carrier-linked prodrugs having reversible carboxylic ester linkages
|
|
US8524939B2
(en)
|
2011-08-24 |
2013-09-03 |
Chirogate International Inc. |
Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
|
|
US9387214B2
(en)
|
2012-01-13 |
2016-07-12 |
United Therapeutics Corporation |
Method of identifying therapies for pulmonary hypertension
|
|
ME02861B
(me)
|
2012-06-15 |
2018-04-20 |
Scipharm Sarl |
Postupak za pripremu treprostinila i njegovih derivata
|
|
KR102143961B1
(ko)
|
2012-08-01 |
2020-08-12 |
유나이티드 세러퓨틱스 코오포레이션 |
프로스타시클린-처리된 내피 전구 세포를 사용한 폐동맥 고혈압의 치료
|
|
JP6901823B2
(ja)
|
2012-08-01 |
2021-07-14 |
ユナイテッド セラピューティクス コーポレイション |
間葉系幹細胞による肺動脈性高血圧症の処置
|
|
HK1216009A1
(zh)
|
2012-11-30 |
2016-10-07 |
Insmed Incorporated |
前列環素組合物及其使用方法
|
|
WO2014110094A1
(en)
|
2013-01-09 |
2014-07-17 |
United Therapeutics Corporation |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
EP2943479B1
(en)
*
|
2013-01-11 |
2020-04-15 |
Corsair Pharma, Inc. |
Prodrugs of treprostinil
|
|
CA2905720C
(en)
|
2013-03-14 |
2021-10-19 |
United Therapeutics Corporation |
Solid forms of treprostinil
|
|
CA2904598C
(en)
|
2013-03-15 |
2021-10-05 |
United Therapeutics Corporation |
Salts of treprostinil
|
|
WO2014160638A1
(en)
|
2013-03-25 |
2014-10-02 |
United Therapeutics Corporation |
Process of making prostacyclin compounds with linker thiol and pegylated forms
|
|
WO2014179295A1
(en)
|
2013-04-30 |
2014-11-06 |
United Therapeutics Corporation |
Controlled release pharmaceutical formulations
|
|
WO2014203278A2
(en)
|
2013-06-19 |
2014-12-24 |
Msn Laboratories Private Limited |
NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
|
|
CN106132403B
(zh)
|
2013-10-11 |
2020-04-28 |
普尔莫凯恩股份有限公司 |
喷雾干燥制剂
|
|
DK3060041T3
(da)
|
2013-10-25 |
2021-03-22 |
Insmed Inc |
Prostacyclinforbindelser
|
|
WO2015138423A1
(en)
|
2014-03-11 |
2015-09-17 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
EP3164155B1
(en)
|
2014-06-13 |
2022-02-09 |
United Therapeutics Corporation |
Treprostinil formulations
|
|
US9593061B2
(en)
|
2014-10-20 |
2017-03-14 |
United Therapeutics Corporation |
Synthesis of intermediates for producing prostacyclin derivatives
|
|
CA2967385C
(en)
|
2014-11-18 |
2023-05-16 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
|
WO2016176555A1
(en)
|
2015-04-29 |
2016-11-03 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
IL262720B2
(en)
|
2016-05-05 |
2024-06-01 |
Liquidia Tech Inc |
Dry powder treprostinil for the treatment of pulmonary hypertension
|
|
WO2017223400A1
(en)
|
2016-06-24 |
2017-12-28 |
Insmed Incorporated |
Prostacyclin compounds and compositions for treating sarcoidosis
|
|
EP3515430A1
(en)
|
2016-09-26 |
2019-07-31 |
United Therapeutics Corporation |
Treprostinil prodrugs
|
|
EP3673895A1
(en)
|
2018-12-28 |
2020-07-01 |
Université Libre de Bruxelles |
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
|
EP3962472A4
(en)
|
2019-04-29 |
2023-01-25 |
Insmed Incorporated |
DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF
|